Inability to give informed consent
Possible pregnancy (confirmed by urine test)
Women who are breastfeeding
Severe claustrophobia
Inability to lie flat for 20-30 minutes (the anticipated amount of time to complete the MRI procedure)
Individuals with cochlear implants
Individuals with non-MRI compatible aneurysm clips
Potential contraindications to regadenoson use due to:
Contraindication to administration of Gadolinium (Gd) based contrast agents (GBCA):

NCT01446094_exc_T2
Condition
pregnancy
NCT01446094_exc_T3
Mood
Possible
NCT01446094_exc_T4
Procedure
urine test
NCT01446094_exc_T5
Value
confirmed
NCT01446094_exc_T6
Person
Women
NCT01446094_exc_T7
Observation
breastfeeding
NCT01446094_exc_T8
Qualifier
Severe
NCT01446094_exc_T9
Condition
claustrophobia
NCT01446094_exc_T10
Condition
Inability to lie flat
NCT01446094_exc_T11
Qualifier
20-30 minutes
NCT01446094_exc_T12
Qualifier
amount of time to complete the MRI procedure
NCT01446094_exc_T13
Device
cochlear implants
NCT01446094_exc_T14
Device
aneurysm clips
NCT01446094_exc_T15
Qualifier
MRI compatible
NCT01446094_exc_T16
Negation
non
NCT01446094_exc_T18
Drug
Gadolinium (Gd) based contrast agents (GBCA)
NCT01446094_exc_T19
Condition
Contraindication